SMC recommends six products but rejects two for diabetes
This article was originally published in Scrip
Executive Summary
The Scottish Medicines Consortium, in a bumper round of recommendations, has given the go-ahead for six products to be used on Scotland's NHS, including two cancer products. But at the same time, the consortium has denied market access to two diabetes products.